Description
Composition- Sacubitril 97 mg + Valsartan 103 mg
Mode of Action- Provides high-strength ARNI therapy by combining neprilysin inhibition and angiotensin receptor blockade for chronic heart failure control.
USPs- High-strength heart failure management; supports improved cardiac outcomes; dual neurohormonal control.
Prescribing Specialties- Cardiologist, Internal Medicine
